These are the facts:2008: AGM: Shareholders – asked to reward...

These are the facts:

2008:
AGM: Shareholders – asked to reward Parasites
25Aug Preliminary Final Report and Annual Report
25Aug RSV licence assigned to AZ - territories expanded
11Aug Human rhinovirus Phase IIa clinical tiral commences
08Aug Bullsh!t Letter to shareholders
31 Jul LANI Phase II completed - Phase III scheduled
24 Jul Quarterly Royalties from Relenza
21 Jul Announced Cooked Deal as good news
16 Jul Appendix 3B - PARASITES REWARDED

2007:
09Aug Preliminary Final Report
01 Aug Appendix 3B - PARASITES REWARDED
31 Jul Biota raises Relenza claim to A$564 - A$704 million
25 Jul GSK release sales result

2006:
6 Sept: Preliminary Results
30 Aug: Announced Court Trial Dates
25 Aug Announced Relenza EU approval extension
17 Aug: Announced HRV commenced Phase 1b Trial
9 Aug: Appendix 3B – PARASITES REWARDED
8 Aug: Announced $8.5m NIH award
2 Aug: Announced HRV phase 1 a Clinical Trial results
26 Jul: GSK release sales results

2005:
26Aug Preliminary Final Report
23Aug Appendix 3B - PARASITES REWARDED
15Aug Biota Confirms Relenza Stockpiling in Germany
15Aug Appointment of new CFO
11Aug Reported Relenza Stockpiling in Germany
04Aug Appendix 3B – PARASITES REWARDED
27Jul Values Claim against GSK at $308 to $430 million
25Jul Appendix 3B - PARASITES REWARDED
21Jul Date Changed for Damages Filing in GSK Suit

Observations:
Coincidences or a peculiar pattern of behavior or Cooked Modus Operandi?
In the last 4 years, after GSK had reported the sales results to the day of the BTA results were released, there will be good news and Appendix 3B announcements.

Is 2009 going to be any different? I expect a very good GSK sales report. Then follow by Appendix 3B announcements rewarding Peter Cook as if he single-handedly improved Relenza sales and the company profit, followed by a flurry of Good news?? Maybe LANI, Stockpiling sales; Product development news??